|
|
|
| |
|
|
| |
The latest hepatology news from News Medical |
|
|
|
| |  | | | In a recent work published in BME Frontiers, a collaborative study by researchers from Griffith University, Queensland University of Technology, University of Queensland, and Nanjing Stomatological Hospital has introduced groundbreaking three-dimensional (3D) dynamic cell co-culture models to simulate metabolic dysfunction-associated steatotic liver disease (MASLD) progression stages. | | | | |  DeNovix discusses how customer demand inspired the development of specialized CellDrop applications for hepatocytes and organoids. | | | | | An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent metabolic fatty liver disease from progressing towards more serious conditions, such as cirrhosis or liver cancer. | | | | |  One in four hepatologists in the United States screened positive for unhealthy alcohol use in a survey study conducted by UCLA. | | | | |  Using targeted radiation during surgery - referred to as intraoperative radiation - to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate around the pancreas to 5%. | | | | |  A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). | | | | |  Organ donation following medical assistance in dying (MAiD), also known as euthanasia, is a relatively new practice both in North America and worldwide. | |
|
|
|
|
|
|
|
